Hsbc Holdings PLC Edwards Lifesciences Corp Call Options Transaction History

Hsbc Holdings PLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 12, 2024	BUY	$84.3 - $94.31 $514,230 - $575,291	6,100 New	6,100 $563,000
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $527,156 - $607,489	-6,700 Reduced 24.45%	20,700 $1.73 Million
Q4 2020 Feb 25, 2021	BUY	$71.69 - $91.23 $630,872 - $802,824	8,800 Added 47.31%	27,400 $2.5 Million
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $1.85 Million - $2.41 Million	-27,600 Reduced 59.74%	18,600 $1.5 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $2.01 Million - $2.47 Million	32,700 Added 242.22%	46,200 $10.2 Million
Q2 2019 Aug 13, 2019	SELL	$55.74 - $64.41 $412,476 - $476,634	-7,400 Reduced 35.41%	13,500 $2.49 Million
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $887,205 - $1.07 Million	20,900 New	20,900 $3.04 Million

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.